BDNF (brain-derived neurotrophic factor) is a member of the neurotrophin family, secreted as a non-covalent homodimer of ~13.5 kDa subunits. Mature BDNF binds the receptor tyrosine kinase TrkB with high affinity, triggering Ras-MAPK, PI3K-Akt and PLC-gamma cascades and, downstream, CREB-dependent transcription and AMPA receptor trafficking.
Why BDNF matters as a readout
The precursor is not inert. ProBDNF binds p75NTR with sortilin and drives apoptosis and long-term depression — the biological opposite of mature BDNF's actions — so an assay that fails to distinguish the two can report the wrong direction entirely. Any ELISA used for BDNF should state its pro/mature specificity, and serum values are further confounded by platelet release during clotting.
BDNF appears constantly in nootropic peptide literature because increased BDNF expression is the proposed mechanism cited for Semax, P-21, PE-22-28 and Cerebrolysin, generally from rodent and cell work rather than human outcome trials. The common human Val66Met polymorphism alters activity-dependent secretion and is a standard covariate in cognitive studies.
Related terms and material
nootropic · in vivo · recombinant. Reference material: BDNF research family, Semax, PE-22-28. Further reading: Dihexa vs P-21.